Showing results (421-430 of 1,074) with videos related to

Sort By:
Pageof 108
Therapeutic Advances in Neurological Disorders|September 3, 2013
Therapeutic advances in the management of Pompe disease and other metabolic myopathiesCorrado Angelini, Anna Chiara Nascimbeni, Claudio Semplicini
Therapeutic Advances in Neurological Disorders|March 26, 2026
Psoriasis under B-cell depleting therapies in multiple sclerosis: a retrospective multicenter analysisPatricia Kirschner, Franz F Konen, Franziska Axhausen, et al.
Therapeutic Advances in Neurological Disorders|October 8, 2020
Relapsing and progressive MS: the sex-specific perspectivePaulus Stefan Rommer, David Ellenberger, Kerstin Hellwig, et al.
Therapeutic Advances in Neurological Disorders|June 1, 2026
Complement C5 inhibitors as add-on rescue treatment in severe AQP4-antibody neuromyelitis optica spectrum disorder attacks: a case series and literature reviewKai Xin Gan, Sarah Hasnor Binti Abu Hassan, Xiu Ling Tan, et al.
Therapeutic Advances in Neurological Disorders|April 24, 2026
Preliminary observations on the efficacy of efgartigimod in anti-LGI1-associated autoimmune encephalitisJing-Wen Zuo, Ying-Yue Dai, Wen-Jing Liu, et al.
Therapeutic Advances in Neurological Disorders|May 15, 2026
Biochemical and nutritional changes during continuous subcutaneous apomorphine infusion in advanced Parkinson's disease: findings from an observational cohortOnanong Phokaewvarangkul, Naruemon Rattanapitak, Panthitra Kuwattanasuchati, et al.
Therapeutic Advances in Neurological Disorders|February 23, 2026
Vedolizumab and the gut-CNS axis in multiple sclerosis: considering T cell licensing pathwaysAfsaneh Shirani, Olaf Stuve
Therapeutic Advances in Neurological Disorders|November 16, 2022
Assessing the immune response to SARS-CoV-2 mRNA vaccines in siponimod-treated patients: a nonrandomized controlled clinical trial (AMA-VACC)Tjalf Ziemssen, Marie Groth, Benedict Rauser, et al.
Therapeutic Advances in Neurological Disorders|November 2, 2016
Two-year real-world experience with perampanel in patients with refractory focal epilepsy: Austrian dataAlexandra Rohracher, Gudrun Kalss, Markus Leitinger, et al.
Therapeutic Advances in Neurological Disorders|March 4, 2014
Tolcapone addition improves Parkinson's disease associated nonmotor symptomsThomas Müller,
Pageof 108